Schedule 13G ownership disclosure
aTyr Pharma Inc
Security class unavailable · CUSIP: 002120202
Event date: 2023-12-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,800,000
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-24-000001
- Form type
- SC 13G
- Filer
- Logos Global Management LP
- CIK
- CIK 1792126
- Filed
- Jan 02, 2024
- Reporting period
- Dec 19, 2023
- Description
- Schedule 13G beneficial ownership